How does spinal muscular atrophy (SMA) impact the mental health of children and young adults?…
Dr. Lauren WeinandJanuary 18, 2022
This retrospective study, published in the Journal of Neurodevelopmental Disorders, analyzed cognitive function, language comprehension, speech, and…
Dr. Lauren WeinandJanuary 1, 2022
This study, published in Frontiers in Neurology, investigated the relationship between motor functioning and neck and…
Dr. Lauren WeinandJanuary 1, 2022
Spinal muscular atrophy (SMA) can result in neonatal morbidity and mortality. As a result, it…
Dr. Lauren WeinandJanuary 1, 2022
Patients with spinal muscular atrophy (SMA) type 2 typically begin exhibiting symptoms between 6 and…
Dr. Lauren WeinandDecember 31, 2021
Onasemnogene abeparvovec is a gene replacement therapy used to treat type 1 spinal muscular atrophy…
Dr. Lauren WeinandDecember 31, 2021
Spinal muscular atrophy (SMA) is divided into five types based on the age of onset…
Dr. Lauren WeinandDecember 31, 2021
Type 1 SMA is a progressive neuromuscular disease characterized by onset at 6 months of…
Dr. Lauren WeinandDecember 31, 2021
With the COVID-19 pandemic causing nusinersen treatments to be postponed, a study published in Frontiers…
Dr. Lauren WeinandDecember 31, 2021